W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 24.8 HKD -5.16% Market Closed
Market Cap: 29.7B HKD
Have any thoughts about
WuXi XDC Cayman Inc?
Write Note

WuXi XDC Cayman Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

WuXi XDC Cayman Inc
Total Equity Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
W
WuXi XDC Cayman Inc
HKEX:2268
Total Equity
ÂĄ5.5B
CAGR 3-Years
144%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Total Equity
ÂĄ54.7B
CAGR 3-Years
14%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Total Equity
ÂĄ13B
CAGR 3-Years
12%
CAGR 5-Years
36%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Equity
ÂĄ40.7B
CAGR 3-Years
7%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Equity
ÂĄ20.8B
CAGR 3-Years
7%
CAGR 5-Years
41%
CAGR 10-Years
39%
Genscript Biotech Corp
HKEX:1548
Total Equity
$1.4B
CAGR 3-Years
11%
CAGR 5-Years
25%
CAGR 10-Years
N/A

See Also

What is WuXi XDC Cayman Inc's Total Equity?
Total Equity
5.5B CNY

Based on the financial report for Dec 31, 2023, WuXi XDC Cayman Inc's Total Equity amounts to 5.5B CNY.

What is WuXi XDC Cayman Inc's Total Equity growth rate?
Total Equity CAGR 3Y
144%

Over the last year, the Total Equity growth was 268%. The average annual Total Equity growth rates for WuXi XDC Cayman Inc have been 144% over the past three years .

Back to Top